NLM Logo

PEP protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
PEP protocol
Unique ID
C055285
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C055285
Entry Term(s)
EBCi regimen
Registry Number
0
Previous Indexing
BLEOMYCINS (88-93)
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Cisplatin
Etoposide
Peplomycin
Frequency
7
Note
chemotherapy protocol consisting of cisplatin, etoposide and peplomycin; used in treatment of refractory rhabdomyosarcoma of the prostate and testicular teratoma
Source
Hinyokika Kiyo 1987;33(11):1899
Date of Entry
1988/04/22
Revision Date
2000/11/30
PEP protocol Preferred
EBCi regimen Related
page delivered in 0.005s